CMS Medical Technology Advisor Gottlieb Returning To AEI
This article was originally published in The Pink Sheet Daily
He will serve as a fellow at the American Enterprise Institute and plans to launch a new publication in conjunction with Forbes on emerging medical technology. Gottlieb was an AEI fellow prior to joining FDA, where he served as medical policy development director before leaving for CMS.
You may also be interested in...
The council will establish two working groups: the "Better Evidence" group will focus on improving clinical data available for coverage decisions and the "Effective Innovation" group will develop ways to improve the efficiency of the coverage decision process. CMS' Herbert Kuhn and Sean Tunis will co-chair the council.
The Centers for Medicare & Medicaid Services administrator is surrounding himself with some of his closest advisors as CMS gears up to implement the Medicare Rx drug benefit. None of the four staffers had line operation functions at FDA.
The cardiologist panel calls for use of the congestive heart failure therapy to be "strictly limited" to patients that present with symptoms in the hospital setting. The expert panel also recommends that Scios "immediately undertake" a professional educational campaign about Natrecor's appropriate uses.